Ionis Pharmaceuticals Inc IONS
1,008 filings, 7 in the last 30 days
SEC filing indexWhat the 8-Ks said
None of the officer, auditor, restatement, cyber, restructuring, listing, impairment or debt 8-Ks in the last 3 years
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 129 events
- Nov 13, 2026 Buy Hayden Michael R (Director) bought $148Kopen-market purchase on Nov 10, 2026
- Nov 9, 2026 8-K Quarterly results8-K item 2.02
- Nov 9, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Oct 23, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Oct 21, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Oct 16, 2026 Planned sale Devers Shannon L. (Officer) gave notice of a planned sale of 1,357 shares worth about $60KForm 144, approximate sale date Oct 16, 2026
- Sep 23, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Sep 4, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Sep 4, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Jul 31, 2026 Buy Hayden Michael R (Director) bought $1.1Mopen-market purchase on Jul 30, 2026
- Jul 29, 2026 Planned sale Shannon Devers (Executive Vice President, Chief Human Resources Officer) ended a 10b5-1 trading planreported in the 10-Q, runs to Apr 4, 2027
- Jul 29, 2026 8-K Quarterly results8-K item 2.02
- Jul 29, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jul 10, 2026 8-K Regulation FD disclosure8-K item 7.01
- Jul 9, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Jul 7, 2026 Planned sale BENNETT C FRANK (Officer) gave notice of a planned sale of 67,386 shares worth about $5.7MForm 144, approximate sale date Jul 7, 2026, under a 10b5-1 plan adopted Mar 31, 2026
- Jul 7, 2026 Planned sale Kordasiewicz Holly B. (Officer) gave notice of a planned sale of 1,287 shares worth about $108KForm 144, approximate sale date Jul 7, 2026, under a 10b5-1 plan adopted Mar 13, 2026
- Jul 7, 2026 Planned sale Diaz Allene M. (Director) gave notice of a planned sale of 10,111 shares worth about $864KForm 144, approximate sale date Jul 7, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Jul 1, 2026 Planned sale KLEIN JOSEPH III (Director) gave notice of a planned sale of 11,518 shares worth about $910KForm 144, approximate sale date Jul 1, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Jun 26, 2026 Planned sale Schneider Eugene (Officer) gave notice of a planned sale of 47,884 shares worth about $3.9MForm 144, approximate sale date Jun 26, 2026, under a 10b5-1 plan adopted Nov 19, 2025
- Jun 26, 2026 Planned sale O'NEIL PATRICK R. (Officer) gave notice of a planned sale of 3,069 shares worth about $246KForm 144, approximate sale date Jun 26, 2026, under a 10b5-1 plan adopted Dec 8, 2025
- Jun 26, 2026 Planned sale Baroldi Mariana (Member of immediate family of any of the foregoing) gave notice of a planned sale of 5,635 shares worth about $452KForm 144, approximate sale date Jun 26, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Jun 25, 2026 Planned sale Swayze Eric (Officer) gave notice of a planned sale of 10,602 shares worth about $839KForm 144, approximate sale date Jun 25, 2026, under a 10b5-1 plan adopted Mar 6, 2026
- Jun 24, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Jun 15, 2026 Planned sale BERTHELSEN SPENCER R (Director) gave notice of a planned sale of 8,000 shares worth about $588KForm 144, approximate sale date Jun 15, 2026, under a 10b5-1 plan adopted Sep 9, 2025
- Jun 12, 2026 Planned sale Kordasiewicz Holly B. (Officer) gave notice of a planned sale of 60,846 shares worth about $4.5MForm 144, approximate sale date Jun 12, 2026, under a 10b5-1 plan adopted Mar 13, 2026
- Jun 12, 2026 8-K Other events8-K item 8.01
- Jun 8, 2026 8-K Director or officer change, Shareholder vote results, Regulation FD disclosure8-K items 5.02, 5.07, 7.01
- Jun 1, 2026 Planned sale BERTHELSEN SPENCER R (Director) gave notice of a planned sale of 8,000 shares worth about $605KForm 144, approximate sale date Jun 1, 2026, under a 10b5-1 plan adopted Sep 9, 2025
- May 28, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- May 13, 2026 Planned sale Monia Brett P (Officer) gave notice of a planned sale of 100,000 shares worth about $7.8MForm 144, approximate sale date May 13, 2026, under a 10b5-1 plan adopted Dec 8, 2025
- May 4, 2026 Planned sale LOSCALZO JOSEPH (Director) gave notice of a planned sale of 54,321 shares worth about $4.3MForm 144, approximate sale date May 4, 2026, under a 10b5-1 plan adopted Nov 18, 2025
- Apr 29, 2026 Planned sale Eric Swayze (Executive Vice President, Research) ended a 10b5-1 trading planreported in the 10-Q, up to 177,770 shares, runs to Dec 31, 2030
- Apr 29, 2026 Planned sale Holly Kordasiewicz (Executive Vice President, Chief Development Officer) adopted a 10b5-1 trading planreported in the 10-Q, runs to May 31, 2027
- Apr 29, 2026 Planned sale Frank Bennett (Executive Vice President, Chief Scientific Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 67,386 shares, runs to Jul 5, 2027
- Apr 29, 2026 8-K Quarterly results8-K item 2.02
- Apr 29, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Apr 28, 2026 Planned sale Baroldi Joseph (Officer) gave notice of a planned sale of 1,626 shares worth about $117KForm 144, approximate sale date Apr 28, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Apr 21, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Apr 16, 2026 Planned sale Baroldi Joseph (Officer) gave notice of a planned sale of 5,619 shares worth about $424KForm 144, approximate sale date Apr 16, 2026
- Apr 16, 2026 Planned sale Birchler Brian (Officer) gave notice of a planned sale of 973 shares worth about $73KForm 144, approximate sale date Apr 16, 2026
- Apr 16, 2026 Planned sale Jenne Kyle (Officer) gave notice of a planned sale of 4,902 shares worth about $370KForm 144, approximate sale date Apr 16, 2026
- Mar 31, 2026 Planned sale Diaz Allene M. (Director) gave notice of a planned sale of 68,800 shares worth about $5.5MForm 144, approximate sale date Mar 3, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Mar 24, 2026 Planned sale Schneider Eugene (Officer) gave notice of a planned sale of 5,812 shares worth about $412KForm 144, approximate sale date Mar 19, 2026, under a 10b5-1 plan adopted Nov 19, 2025
- Mar 19, 2026 Planned sale Schneider Eugene (Officer) gave notice of a planned sale of 5,812 shares worth about $412KForm 144, approximate sale date Mar 19, 2026, under a 10b5-1 plan adopted Nov 14, 2025
- Mar 16, 2026 Planned sale HOUGEN ELIZABETH L (Officer) gave notice of a planned sale of 225,200 shares worth about $16.3MForm 144, approximate sale date Mar 16, 2026, under a 10b5-1 plan adopted Dec 9, 2025
- Mar 10, 2026 Planned sale Jenne Kyle (Director) gave notice of a planned sale of 58,253 shares worth about $4.4MForm 144, approximate sale date Mar 10, 2026, under a 10b5-1 plan adopted Dec 8, 2025
- Mar 9, 2026 Planned sale O'NEIL PATRICK R. (Officer) gave notice of a planned sale of 13,217 shares worth about $995KForm 144, approximate sale date Mar 9, 2026, under a 10b5-1 plan adopted Dec 8, 2025
- Mar 9, 2026 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- Mar 3, 2026 Planned sale BENNETT C FRANK (Officer) gave notice of a planned sale of 85,089 shares worth about $7.1MForm 144, approximate sale date Mar 3, 2026, under a 10b5-1 plan adopted Nov 19, 2025
- Mar 3, 2026 Planned sale Devers Shannon L. (Officer) gave notice of a planned sale of 39,014 shares worth about $3.1MForm 144, approximate sale date Mar 3, 2026, under a 10b5-1 plan adopted Nov 24, 2025
- Mar 3, 2026 Planned sale KLEIN JOSEPH III (Director) gave notice of a planned sale of 65,345 shares worth about $5.0MForm 144, approximate sale date Mar 3, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Mar 3, 2026 Planned sale Baroldi Joseph (Officer) gave notice of a planned sale of 4,096 shares worth about $325KForm 144, approximate sale date Mar 3, 2026, under a 10b5-1 plan adopted Nov 24, 2025
- Mar 3, 2026 Planned sale Baroldi Mariana (Officer) gave notice of a planned sale of 8,198 shares worth about $656KForm 144, approximate sale date Mar 3, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Mar 3, 2026 Planned sale LOSCALZO JOSEPH (Director) gave notice of a planned sale of 24,000 shares worth about $1.9MForm 144, approximate sale date Mar 3, 2026, under a 10b5-1 plan adopted Nov 18, 2025
- Feb 26, 2026 Planned sale Allene Diaz (Board Member) ended a 10b5-1 trading planreported in the 10-K, up to 68,800 shares, runs to Feb 28, 2027
- Feb 26, 2026 Planned sale Joseph Loscalzo (Board Member) adopted a 10b5-1 trading planreported in the 10-K, up to 78,321 shares, runs to Jan 31, 2027
- Feb 26, 2026 Planned sale Eugene Schneider (Executive Vice President, Chief Clinical Development and Operations Officer) adopted a 10b5-1 trading planreported in the 10-K, runs to Feb 14, 2027
- Feb 26, 2026 Planned sale Frank Bennett (Executive Vice President, Chief Scientific Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 85,089 shares, runs to Feb 1, 2027
- Feb 26, 2026 Planned sale Joseph Baroldi (Executive Vice President, Chief Business Officer) ended a 10b5-1 trading planreported in the 10-K, up to 87,874 shares, runs to Feb 28, 2027
- Feb 26, 2026 Planned sale Shannon Devers (Executive Vice President, Chief Human Resources Officer) adopted a 10b5-1 trading planreported in the 10-K, runs to Apr 4, 2027
- Feb 26, 2026 Planned sale Joseph Klein (Board Member) adopted a 10b5-1 trading planreported in the 10-K, up to 62,282 shares, runs to Jun 30, 2027
- Feb 26, 2026 Planned sale Brett Monia (Chief Executive Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 260,773 shares, runs to Sep 30, 2028
- Feb 26, 2026 Planned sale Kyle Jenne (Executive Vice President, Chief Global Product Strategy Officer) adopted a 10b5-1 trading planreported in the 10-K, runs to Jun 30, 2027
- Feb 26, 2026 Planned sale Patrick O'Neil (Executive Vice President, Chief Legal Officer and General Counsel) ended a 10b5-1 trading planreported in the 10-K, up to 237,477 shares, runs to Jun 1, 2027
- Feb 26, 2026 Planned sale Elizabeth Hougen (Executive Vice President, Finance and Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-K, runs to Feb 28, 2028
- Feb 26, 2026 Planned sale Joseph Wender (Board Member) adopted a 10b5-1 trading planreported in the 10-K, up to 70,000 shares, runs to Dec 31, 2026
- Feb 26, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Feb 25, 2026 8-K Quarterly results8-K item 2.02
- Feb 13, 2026 Planned sale Swayze Eric (Officer) gave notice of a planned sale of 15,642 shares worth about $1.3MForm 144, approximate sale date Feb 13, 2026, under a 10b5-1 plan adopted Aug 14, 2024
- Feb 11, 2026 Planned sale PARSHALL B LYNNE (Director) gave notice of a planned sale of 10,000 shares worth about $827KForm 144, approximate sale date Feb 11, 2026, under a 10b5-1 plan adopted May 6, 2025
- Feb 6, 2026 Planned sale Monia Brett P (Officer) gave notice of a planned sale of 290,203 shares worth about $24.8MForm 144, approximate sale date Feb 6, 2026, under a 10b5-1 plan adopted Aug 12, 2024
- Feb 2, 2026 Planned sale BENNETT C FRANK (Officer) gave notice of a planned sale of 85,089 shares worth about $7.1MForm 144, approximate sale date Feb 2, 2026, under a 10b5-1 plan adopted Nov 19, 2025
- Jan 30, 2026 Planned sale Schneider Eugene (Officer) gave notice of a planned sale of 6,179 shares worth about $513KForm 144, approximate sale date Jan 30, 2026
- Jan 30, 2026 Planned sale Swayze Eric (Officer) gave notice of a planned sale of 6,179 shares worth about $513KForm 144, approximate sale date Jan 30, 2026
- Jan 30, 2026 Planned sale O'NEIL PATRICK R. (Officer) gave notice of a planned sale of 6,179 shares worth about $513KForm 144, approximate sale date Jan 30, 2026
- Jan 30, 2026 Planned sale Monia Brett P (Officer, Director) gave notice of a planned sale of 62,970 shares worth about $5.2MForm 144, approximate sale date Jan 30, 2026
- Jan 30, 2026 Planned sale HOUGEN ELIZABETH L (Officer) gave notice of a planned sale of 6,988 shares worth about $580KForm 144, approximate sale date Jan 30, 2026
- Jan 30, 2026 Planned sale BENNETT C FRANK (Officer) gave notice of a planned sale of 5,885 shares worth about $488KForm 144, approximate sale date Jan 30, 2026
- Jan 30, 2026 Planned sale Birchler Brian (Officer) gave notice of a planned sale of 6,179 shares worth about $512KForm 144, approximate sale date Jan 30, 2026
- Jan 30, 2026 Planned sale Baroldi Joseph (Officer) gave notice of a planned sale of 5,296 shares worth about $440KForm 144, approximate sale date Jan 30, 2026
- Jan 23, 2026 Planned sale Devers Shannon L. (Officer) gave notice of a planned sale of 3,977 shares worth about $323KForm 144, approximate sale date Jan 22, 2026, under a 10b5-1 plan adopted Sep 3, 2024
- Jan 22, 2026 Planned sale Devers Shannon L. (Officer) gave notice of a planned sale of 3,977 shares worth about $323KForm 144, approximate sale date Jan 22, 2026, under a 10b5-1 plan adopted Sep 3, 2024
- Jan 21, 2026 Planned sale Baroldi Mariana (Member of immediate family of any of the foregoing) gave notice of a planned sale of 1,171 shares worth about $94KForm 144, approximate sale date Jan 16, 2026
- Jan 16, 2026 Planned sale Devers Shannon L. (Officer) gave notice of a planned sale of 8,353 shares worth about $637KForm 144, approximate sale date Jan 16, 2026
- Jan 16, 2026 Planned sale Jenne Kyle (Officer) gave notice of a planned sale of 1,823 shares worth about $139KForm 144, approximate sale date Jan 16, 2025
- Jan 16, 2026 Planned sale Schneider Eugene (Officer) gave notice of a planned sale of 9,302 shares worth about $709KForm 144, approximate sale date Jan 16, 2026
- Jan 16, 2026 Planned sale O'NEIL PATRICK R. (Officer) gave notice of a planned sale of 9,191 shares worth about $701KForm 144, approximate sale date Jan 16, 2026
- Jan 16, 2026 Planned sale Kordasiewicz Holly B. (Officer) gave notice of a planned sale of 4,141 shares worth about $315KForm 144, approximate sale date Jan 16, 2025
- Jan 16, 2026 Planned sale Monia Brett P (Officer, Director) gave notice of a planned sale of 44,034 shares worth about $3.4MForm 144, approximate sale date Jan 16, 2026
- Jan 16, 2026 Planned sale HOUGEN ELIZABETH L (Officer) gave notice of a planned sale of 12,922 shares worth about $985KForm 144, approximate sale date Jan 16, 2026
- Jan 16, 2026 Planned sale Birchler Brian (Officer) gave notice of a planned sale of 8,480 shares worth about $646KForm 144, approximate sale date Jan 16, 2026
- Jan 16, 2026 Planned sale BENNETT C FRANK (Officer) gave notice of a planned sale of 8,977 shares worth about $684KForm 144, approximate sale date Jan 16, 2026
- Jan 16, 2026 Planned sale Baroldi Joseph (Officer) gave notice of a planned sale of 6,999 shares worth about $560KForm 144, approximate sale date Jan 16, 2026
- Jan 16, 2026 Planned sale Swayze Eric (Officer) gave notice of a planned sale of 9,884 shares worth about $754KForm 144, approximate sale date Jan 16, 2026
- Jan 12, 2026 8-K Quarterly results8-K item 2.02
- Jan 7, 2026 Planned sale Devers Shannon L. (Officer) gave notice of a planned sale of 9,390 shares worth about $795KForm 144, approximate sale date Jan 7, 2026, under a 10b5-1 plan adopted Sep 3, 2024
- Jan 7, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Jan 2, 2026 Planned sale Swayze Eric (Officer) gave notice of a planned sale of 23,463 shares worth about $1.6MForm 144, approximate sale date Jan 2, 2026, under a 10b5-1 plan adopted Aug 14, 2024
- Dec 1, 2025 Planned sale Joseph Wender (Director) gave notice of a planned sale of 33,600 shares worth about $2.5MForm 144, approximate sale date Oct 30, 2025, under a 10b5-1 plan adopted Dec 26, 2024
- Dec 1, 2025 Planned sale Joseph Wender (Director) gave notice of a planned sale of 14,479 shares worth about $1.2MForm 144, approximate sale date Dec 1, 2025, under a 10b5-1 plan adopted Dec 26, 2024
- Nov 25, 2025 Planned sale KLEIN JOSEPH III (Director) gave notice of a planned sale of 12,000 shares worth about $960KForm 144, approximate sale date Nov 25, 2025, under a 10b5-1 plan adopted Jan 3, 2024
- Nov 25, 2025 Planned sale Devers Shannon L. (Officer) gave notice of a planned sale of 42,322 shares worth about $3.4MForm 144, approximate sale date Nov 25, 2025, under a 10b5-1 plan adopted Sep 3, 2024
- Nov 19, 2025 Planned sale Joan E. Herman (Director) gave notice of a planned sale of 44,000 shares worth about $3.3MForm 144, approximate sale date Nov 19, 2025
- Nov 17, 2025 8-K Material agreement signed, New debt or obligation, Unregistered share sale, Other events8-K items 1.01, 2.03, 3.02, 8.01
- Nov 10, 2025 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Nov 3, 2025 8-K Material agreement signed (amended)8-K item 1.01
- Oct 29, 2025 8-K Quarterly results8-K item 2.02
- Oct 29, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Sep 22, 2025 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Sep 2, 2025 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Aug 21, 2025 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Jul 30, 2025 Planned sale Eugene Schneider (Chief Clinical Development and Operations Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 38,756 shares, runs to Aug 3, 2026
- Jul 30, 2025 Planned sale Joseph Baroldi (Chief Business Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 87,874 shares, runs to Aug 3, 2026
- Jul 30, 2025 Planned sale Patrick O' Neil (Chief Legal Officer and General Counsel) adopted a 10b5-1 trading planreported in the 10-Q, up to 237,477 shares, runs to Aug 3, 2026
- Jul 30, 2025 Planned sale B. Lynne Parshall (Board Member) adopted a 10b5-1 trading planreported in the 10-Q, up to 41,993 shares, runs to May 31, 2026
- Jul 30, 2025 Planned sale Frank Bennett (Chief Scientific Officer) ended a 10b5-1 trading planreported in the 10-Q, up to 67,800 shares, runs to Aug 17, 2026
- Jul 30, 2025 Planned sale Richard Geary (Chief Development Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 220,870 shares, runs to Jul 31, 2026
- Jul 30, 2025 8-K Quarterly results8-K item 2.02
- Jul 30, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Jun 12, 2025 8-K Director or officer change8-K item 5.02
- Jun 10, 2025 8-K Shareholder vote results8-K item 5.07
- May 19, 2025 8-K Other events8-K item 8.01
- Apr 30, 2025 8-K Quarterly results8-K item 2.02
- Apr 30, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Mar 12, 2025 8-K Material agreement signed8-K item 1.01
- Feb 19, 2025 8-K Quarterly results8-K item 2.02
- Feb 19, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Dec 20, 2024 8-K Other events8-K item 8.01
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 13, 2026 | 4 | Insider trade |
| Nov 9, 2026 | 8-K | Quarterly results |
| Nov 9, 2026 | 10-Q | Quarterly report |
| Oct 23, 2026 | 8-K | Regulation FD disclosure, Other events |
| Oct 21, 2026 | 8-K | Regulation FD disclosure, Other events |
| Oct 19, 2026 | 4 | Insider trade |
| Oct 19, 2026 | 4 | Insider trade |
| Oct 16, 2026 | 144 | Notice of planned insider sale |
| Sep 23, 2026 | 8-K | Regulation FD disclosure, Other events |
| Sep 4, 2026 | 8-K | Regulation FD disclosure, Other events |
| Sep 4, 2026 | 8-K | Regulation FD disclosure, Other events |
| Sep 2, 2026 | 4 | Insider trade |
| Sep 2, 2026 | 4 | Insider trade |
| Sep 2, 2026 | 4 | Insider trade |
| Sep 2, 2026 | 4 | Insider trade |
| Jul 31, 2026 | S-8 | Shares registered for employee plans |
| Jul 31, 2026 | 4 | Insider trade |
| Jul 29, 2026 | 8-K | Quarterly results |
| Jul 29, 2026 | 10-Q | Quarterly report |
| Jul 17, 2026 | 4 | Insider trade |
| Jul 17, 2026 | 4 | Insider trade |
| Jul 17, 2026 | 4 | Insider trade |
| Jul 17, 2026 | 4 | Insider trade |
| Jul 10, 2026 | 8-K | Regulation FD disclosure |
| Jul 9, 2026 | 8-K | Regulation FD disclosure, Other events |
| Jul 9, 2026 | 4 | Insider trade |
| Jul 9, 2026 | 4 | Insider trade |
| Jul 9, 2026 | 4 | Insider trade |
| Jul 7, 2026 | 144 | Notice of planned insider sale |
| Jul 7, 2026 | 144 | Notice of planned insider sale |
| Jul 7, 2026 | 144 | Notice of planned insider sale |
| Jul 6, 2026 | 4 | Insider trade |
| Jul 6, 2026 | 4 | Insider trade |
| Jul 6, 2026 | 4 | Insider trade |
| Jul 6, 2026 | 4 | Insider trade |
| Jul 6, 2026 | 4 | Insider trade |
| Jul 6, 2026 | 4 | Insider trade |
| Jul 6, 2026 | 4 | Insider trade |
| Jul 1, 2026 | 144 | Notice of planned insider sale |
| Jun 30, 2026 | 4 | Insider trade |
| Jun 30, 2026 | 4 | Insider trade |
| Jun 30, 2026 | 4 | Insider trade |
| Jun 26, 2026 | 144 | Notice of planned insider sale |
| Jun 26, 2026 | 144 | Notice of planned insider sale |
| Jun 26, 2026 | 144 | Notice of planned insider sale |
| Jun 26, 2026 | 4 | Insider trade |
| Jun 26, 2026 | 4 | Insider trade |
| Jun 25, 2026 | 144 | Notice of planned insider sale |
| Jun 24, 2026 | 8-K | Regulation FD disclosure, Other events |
| Jun 16, 2026 | 4 | Insider trade |
| Jun 16, 2026 | 4 | Insider trade |
| Jun 15, 2026 | 144 | Notice of planned insider sale |
| Jun 12, 2026 | 144 | Notice of planned insider sale |
| Jun 12, 2026 | 8-K | Other events |
| Jun 8, 2026 | 8-K | Director or officer change, Shareholder vote results, Regulation FD disclosure |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 3 | New insider |
| Jun 8, 2026 | 3 | New insider |
| Jun 3, 2026 | 4 | Insider trade |
| Jun 1, 2026 | 144 | Notice of planned insider sale |
| May 28, 2026 | 8-K | Regulation FD disclosure, Other events |
| May 15, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| May 15, 2026 | 4 | Insider trade |
| May 14, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| May 13, 2026 | 144 | Notice of planned insider sale |
| May 6, 2026 | 4 | Insider trade |
| May 5, 2026 | 4 | Insider trade |
| May 4, 2026 | 144 | Notice of planned insider sale |
| Apr 30, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 30, 2026 | 4 | Insider trade |
| Apr 29, 2026 | 8-K | Quarterly results |
| Apr 29, 2026 | 10-Q | Quarterly report |
| Apr 28, 2026 | 144 | Notice of planned insider sale |
| Apr 23, 2026 | ARS | Annual report to shareholders |
| Apr 23, 2026 | DEFA14A | Extra proxy material |
| Apr 23, 2026 | DEF 14A | Proxy statement |
| Apr 21, 2026 | 8-K | Regulation FD disclosure, Other events |
| Apr 17, 2026 | 4 | Insider trade |
| Apr 17, 2026 | 4 | Insider trade |
| Apr 17, 2026 | 4 | Insider trade |
| Apr 17, 2026 | 4 | Insider trade |
| Apr 16, 2026 | 144 | Notice of planned insider sale |
| Apr 16, 2026 | 144 | Notice of planned insider sale |
| Apr 16, 2026 | 144 | Notice of planned insider sale |
| Apr 2, 2026 | 4 | Insider trade |
| Apr 2, 2026 | 4 | Insider trade |
| Mar 31, 2026 | 144 | Notice of planned insider sale |
| Mar 27, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Mar 24, 2026 | 144/A | Notice of planned insider sale (amended) |
| Mar 23, 2026 | 4 | Insider trade |
| Mar 19, 2026 | 144 | Notice of planned insider sale |
| Mar 18, 2026 | 4 | Insider trade |
| Mar 16, 2026 | 144 | Notice of planned insider sale |
| Mar 11, 2026 | 4 | Insider trade |
| Mar 11, 2026 | 4 | Insider trade |
| Mar 11, 2026 | 4 | Insider trade |
| Mar 10, 2026 | 144 | Notice of planned insider sale |
| Mar 9, 2026 | 144 | Notice of planned insider sale |
| Mar 9, 2026 | 8-K | Director or officer change, Regulation FD disclosure |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/IONS/export.csv") into a cell.